


The fund seeks long term growth.
| Name | % Net Assets | 
|---|---|
| Royal Dutch Shell 'B' | 5.1% | 
| BP | 4.9% | 
| HSBC | 4.4% | 
| British American Tobacco | 3.5% | 
| AstraZeneca | 3.4% | 
| GlaxoSmithKline | 3.4% | 
| Vodafone | 3.3% | 
| Rio Tinto | 3.2% | 
| Royal Bank of Scotland | 3.0% | 
| Aviva | 2.9% | 
| Key | % Net Assets | 
|---|---|
| 5.1% | |
| 4.9% | |
| 4.4% | |
| 3.5% | |
| 82.1% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 184.70p | 
| Currency | GBP | 
| Change | 0.66p | 
| % | 0.36% | 
| YTD change | 5.73p | 
| YTD % | 3.20% | 
| Fund Inception | 09/05/2006 | 
|---|---|
| Fund Manager | SRI Team and Pan-European Equities Team | 
| TER | - | 
| Minimum Investment | |
|---|---|
| Initial | £500 | 
| Additional | n/a | 
| Savings | £50 | 
| Charges | |
|---|---|
| Initial | 4.25% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research